Drug Profile
Ilaprazole - Il Yang
Alternative Names: Aldenon; Aldenonc; IY-81149; IY-NT-R; IY-NT-T; Noltec; Yi Li AnLatest Information Update: 08 Mar 2024
Price :
$50
*
At a glance
- Originator Il-Yang
- Developer Il-Yang; Livzon Pharmaceuticals; Takeda
- Class Antiulcers; Benzimidazoles; Gastric antisecretories; Organic sulfur compounds; Pyridines; Pyrroles; Small molecules; Sulfoxides
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Marketed Gastro-oesophageal reflux; Peptic ulcer; Reflux oesophagitis
Most Recent Events
- 29 Feb 2024 Il-Yang plans a phase III trial for Peptic ulcer (Prevention) in South Korea (PO) in August 2024 (NCT06284876)
- 26 Jun 2023 Il-Yang Pharm completes a phase I trial in healthy volunteers in South Korea (PO) (NCT05237297)
- 22 Dec 2022 Il-Yang Pharm completes a phase I pharmacokinetic trial in South Korea (NCT05558150)